Vidyya Medical News Service
Volume 7 Issue 91 Published - 14:00 UTC 08:00 EST 1-Apr-2005 Next Update - 14:00 UTC 08:00 EST 2-Apr-2005
little clear gif used for spacer

Radiation therapy for prostate cancer nearly doubles risk for rectal cancer
A University of Minnesota Cancer Center study indicates that men who undergo radiation therapy for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer.  more

Chronic pain treatments more effective when taken together
People suffering from chronic, debilitating pain caused by nerve damage or disease report better pain relief at lower doses of a combined drug treatment than from either drug administered individually, a new Queen’s study funded by the Canadian Institutes of Health Research (CIHR) shows.  more

Inexpensive treatment stops multi-drug resistant TB in its tracks
A standard and inexpensive tuberculosis treatment regimen cut the overall TB rate in half and lowered the rate of drug-resistant cases even more dramatically in a remote Mexican health district with a high prevalence of the disease. “This shows what basic TB control can accomplish,” said Maria de Lourdes García García, a Howard Hughes Medical Institute international research scholar who led the Mexican study.  more


Long-term survival in lung transplantation
Based on a study of 752 French patients who underwent either lung or heart-lung transplantation, investigators revealed a close relationship between graft ischemic time and long-term survival after single or double lung transplantation.  more

FDA approves new treatment for chronic hepatitis B
The Food and Drug Administration (FDA) announced the approval of Baraclude (entecavir) tablets and oral solution for the treatment of chronic hepatitis B in adults.  more

Prescribing information: Baraclude (entecavir)
Baraclude (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where the virus is multiplying and damaging the liver. Baraclude does not cure HBV or stop you from spreading HBV to others.  more

NCI researchers confirm the effectiveness of immunotherapy approach to treating melanoma
A team of researchers, led by Steven A. Rosenberg, M.D., at the National Cancer Institute, part of the National Institutes of Health, have found that patients with advanced melanoma who had not responded to previous therapies experienced a significant reduction in the size of their cancers as a result of receiving a new immunotherapy. more

little clear gif used for a space